PGE2抑制肿瘤坏死因子诱导的成骨细胞凋亡

前列腺素E2(PGE2)通过自分泌或旁分泌方式调节成骨细胞的增殖和分化。本文以小鼠原代成骨细胞和成骨样细胞MC3T3-E1为实验材料,研究了PGE2对肿瘤坏死因子α(TNF-α)诱导的成骨细胞凋亡的调节作用。检测发现,振荡型流体剪切力(OFSS)刺激可诱导成骨细胞内环氧合酶2(COX-2)表达升高,进而促进PGE2合成,并抑制TNF-α诱导的成骨细胞凋亡。COX-2选择性活性抑制剂NS-398显著促进TNF-α诱导的成骨细胞内半胱天冬酶3(caspase-3)的激活,且呈时间依赖性。Hoechst 33258/PI染色检测发现,NS-398促使TNF-α诱导的成骨细胞膜通透性进一步增强,核染色质浓缩加剧,而PGE2可显著抑制这一效应。Caspase-3活性检测证实,NS-398显著促进TNF-α诱导的成骨细胞内caspase-3活性增强,外源性PGE2可有效对抗该效应。这些结果表明,内源性和外源性PGE2可抑制TNF-α诱导的成骨细胞凋亡发生。     

Super-Resolution Microscopy Reveals the Native Ultrastructure of the Erythrocyte Cytoskeleton

1. Download high-res image (426KB)
2. Download full-size image

     

枯草芽孢杆菌JA抗菌物特性的研究及抗菌肽的分离纯化

枯草芽孢杆菌JA分泌物中具有抑菌作用的粗提液通过DEAESepharose FF、SOURCE 15 PHE、Sephacry1 S200HR和反相HPLC多步柱层析分离纯化后,获得3种对水稻纹枯和小麦赤霉病菌均有抑菌作用的抗菌肽AFP1、AFP2和AFP3。MALDITOF质谱法测得其分子量分别为1462.645D、1476.390D和1490.530D。氨基酸组成分析结果表明,AFP1和AFP3由苏氨酸、异亮氨酸、酪氨酸、脯氨酸等多种氨基酸组成。目标产物热稳定性好、对蛋白酶有一定的耐受性,推断很可能是低分子量的环状脂肽。     

小麦珠心细胞衰退过程酸性磷酸酶的超微细胞化学定位(英文)

采用磷酸铅盐沉淀技术对小麦（ Ｔｒｉｔｉｃｕｍ ａｅｓｔｉｖｕｍ Ｌ．） 珠心细胞衰退过程进行了酸性磷酸酶的超微细胞化学定位研究。结果显示,在未有明显衰退迹象的一些珠心细胞中,酸性磷酸酶只出现在细胞核轻微凝聚的染色质上。随珠心细胞衰退程度的逐渐增大,其衰退特征越来越明显,酸性磷酸酶依次在细胞质中较小液泡、细胞壁、线粒体、质体以及内质网等结构上出现活性反应。紧连胚囊的珠心细胞衰退程度最大,细胞严重变形,酸性磷酸酶定位于细胞绝大部分结构中,但此时变形的细胞核则无酸性磷酸酶活性反应。研究结果表明,小麦珠心细胞的衰退过程中,酸性磷酸酶存在一个有规律的变化,支持珠心细胞的衰退是属于细胞程序性死亡类型的观点     

糙皮侧耳生长发育过程中漆酶基因家族的表达研究

漆酶参与木质素的降解和食用菌的生长发育。为了明晰漆酶基因在糙皮侧耳生长发育过程中的作用,本文采用real-time PCR检测了11条漆酶基因及Lacc2的小亚基sspoxa3在糙皮侧耳生长发育不同阶段的表达。其中lacc6和sspoxa3在整个生长发育阶段表达量均较高;lacc12随着原基的分化和子实体的形成大量表达,与成菇过程有关。lacc4,lacc7和lacc11在原基分化期高表达,与原基的分化有关。lacc2,lacc3和lacc8在成熟子实体阶段表达量显著上升,与子实体的分化和成熟有关。     

4-Bicyclic heteroaryl-piperidine derivatives as potent,orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: Urea-based analogs

A new series of urea-based, 4-bicyclic heteroaryl-piperidine derivatives as potent SCD1 inhibitors is described. The structure–activity relationships focused on bicyclic heteroarenes and aminothiazole–urea portions are discussed. A trend of dose-dependent decrease in body weight gain in diet-induced obese (DIO) mice is also demonstrated.     

Unmasking differential effects of rosiglitazone and pioglitazone in the combination treatment with n-3 fatty acids in mice fed a high-fat diet

Combining pharmacological treatments and life style interventions is necessary for effective therapy of major diseases associated with obesity, which are clustered in the metabolic syndrome. Acting via multiple mechanisms, combination treatments may reduce dose requirements and, therefore, lower the risk of adverse side effects, which are usually associated with long-term pharmacological interventions. Our previous study in mice fed high-fat diet indicated additivity in preservation of insulin sensitivity and in amelioration of major metabolic syndrome phenotypes by the combination treatment using n-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFA) and rosiglitazone, i.e. an anti-diabetic drug of the thiazolidinedione (TZD) family. We investigated here whether pioglitazone, a TZD-drug in clinical use, could elicit the additive beneficial effects when combined with n-3 LC-PUFA. Adult male mice (C57BL/6N) were fed an obesogenic corn oil-based high-fat diet (cHF) for 8 weeks, or randomly assigned to various dietary treatments (i) cHF+F, cHF with n-3 LC-PUFA concentrate replacing 15% of dietary lipids; (ii) cHF+ROSI, cHF with 10 mg rosiglitazone/kg diet; (iii) cHF+F+ROSI; (iv) cHF+PIO, cHF with 50 mg pioglitazone/kg diet; and (v) cHF+F+PIO, or chow-fed. Plasma concentrations of 163 metabolites were evaluated using a targeted metabolomics approach. Both TZDs preserved glucose homeostasis and normal plasma lipid levels while inducing adiponectin, with pioglitazone showing better effectiveness. The beneficial effects of TZDs were further augmented by the combination treatments. cHF+F+ROSI but not cHF+F+PIO counteracted development of obesity, in correlation with inducibility of fatty acid β-oxidation, as revealed by the metabolomic analysis. By contrast, only cHF+F+PIO eliminated hepatic steatosis and this treatment also reversed insulin resistance in dietary obese mice. Our results reveal differential effects of rosiglitazone and pioglitazone, unmasked in the combination treatment with n-3 LC-PUFA, and support the notion that n-3 LC-PUFA could be used as add-on treatment to TZDs in order to improve diabetic patient's therapy.     

气候平均值变化对辽宁水稻延迟型冷害评估结果的影响

5-9月平均气温和的距平值(ΔT_5-9)是评估东北地区水稻延迟型冷害的常用指标,但5-9月平均气温和的气候平均值(∑T_5-9)统计年代的变化,是否会影响辽宁水稻延迟型冷害评估结果,还有待进一步研究.本文利用中华人民共和国气象行业标准《水稻冷害评估技术规范》(QX/T 182-2013)和补充后的（ΔT_5-9）,通过计算辽宁52个气象站1961-1990(S₁)、1971-2000(S₂)、1981-2010(S₃)和1961-2010年(S₄)4个气候年代的∑T_5-9,分别利用冷害发生站数与评估总站数的比值(IOC)和发生频率对辽宁水稻低温冷害时空变化进行分析.结果表明: 1961-2010年,辽宁各地水稻生长季的热量条件(即∑T_5-9)明显增加并发生了显著的时空变化;利用二次多项式模型对原有的水稻延迟型冷害评估气象指标进行补充完善.S2和S4的气候平均值对研究区水稻延迟型冷害时空规律的判识结果较为相似,但并不完全相同,基于S3气候平均值计算的IOC变异系数均低于其他3个气候平均值计算的IOC变异系数.与水稻典型减产年相比,利用S3气候平均值评估研究期间辽宁水稻延迟型冷害的结果更符合实际情况,可为准确评估气候变化背景下辽宁水稻延迟型冷害时空变化规律提供依据.     

Stromal cell‐derived factor‐1/Exendin‐4 cotherapy facilitates the proliferation,migration and osteogenic differentiation of human periodontal ligament stem cells in vitro and promotes periodontal bone regeneration in vivo

ObjectivesStromal cell‐derived factor‐1 (SDF‐1) actively directs endogenous cell homing. Exendin‐4 (EX‐4) promotes stem cell osteogenic differentiation. Studies revealed that EX‐4 strengthened SDF‐1‐mediated stem cell migration. However, the effects of SDF‐1 and EX‐4 on periodontal ligament stem cells (PDLSCs) and bone regeneration have not been investigated. In this study, we aimed to evaluate the effects of SDF‐1/EX‐4 cotherapy on PDLSCs in vitro and periodontal bone regeneration in vivo.MethodsCell‐counting kit‐8 (CCK8), transwell assay, qRT‐PCR and western blot were used to determine the effects and mechanism of SDF‐1/EX‐4 cotherapy on PDLSCs in vitro. A rat periodontal bone defect model was developed to evaluate the effects of topical application of SDF‐1 and systemic injection of EX‐4 on endogenous cell recruitment, osteoclastogenesis and bone regeneration in vivo.ResultsSDF‐1/EX‐4 cotherapy had additive effects on PDLSC proliferation, migration, alkaline phosphatase (ALP) activity, mineral deposition and osteogenesis‐related gene expression compared to SDF‐1 or EX‐4 in vitro. Pretreatment with ERK inhibitor U0126 blocked SDF‐1/EX‐4 cotherapy induced ERK signal activation and PDLSC proliferation. SDF‐1/EX‐4 cotherapy significantly promoted new bone formation, recruited more CXCR4⁺ cells and CD90⁺/CD34^‐ stromal cells to the defects, enhanced early‐stage osteoclastogenesis and osteogenesis‐related markers expression in regenerated bone compared to control, SDF‐1 or EX‐4 in vivo.ConclusionsSDF‐1/EX‐4 cotherapy synergistically regulated PDLSC activities, promoted periodontal bone formation, thereby providing a new strategy for periodontal bone regeneration.